Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7QSD

Bovine complex I in the active state at 3.1 A

7QSD の概要
エントリーDOI10.2210/pdb7qsd/pdb
EMDBエントリー14127
分子名称NADH-ubiquinone oxidoreductase chain 3, NADH-ubiquinone oxidoreductase chain 6, NADH-ubiquinone oxidoreductase chain 4L, ... (56 entities in total)
機能のキーワードcomplex i, oxidoreductase
由来する生物種Bos taurus (cattle)
詳細
タンパク質・核酸の鎖数45
化学式量合計1071016.18
構造登録者
Bridges, H.R.,Blaza, J.N.,Yin, Z.,Chung, I.,Hirst, J. (登録日: 2022-01-13, 公開日: 2022-03-02, 最終更新日: 2023-03-08)
主引用文献Bridges, H.R.,Blaza, J.N.,Yin, Z.,Chung, I.,Pollak, M.N.,Hirst, J.
Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides.
Science, 379:351-357, 2023
Cited by
PubMed Abstract: The molecular mode of action of biguanides, including the drug metformin, which is widely used in the treatment of diabetes, is incompletely characterized. Here, we define the inhibitory drug-target interaction(s) of a model biguanide with mammalian respiratory complex I by combining cryo-electron microscopy and enzyme kinetics. We interpret these data to explain the selectivity of biguanide binding to different enzyme states. The primary inhibitory site is in an amphipathic region of the quinone-binding channel, and an additional binding site is in a pocket on the intermembrane-space side of the enzyme. An independent local chaotropic interaction, not previously described for any drug, displaces a portion of a key helix in the membrane domain. Our data provide a structural basis for biguanide action and enable the rational design of medicinal biguanides.
PubMed: 36701435
DOI: 10.1126/science.ade3332
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.1 Å)
構造検証レポート
Validation report summary of 7qsd
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon